
    
      1. Compounds:

             1. BOTOX Cosmetic (onabotulinumtoxinA) for Injection

             2. JUVEDERM Ultra XC and JUVEDERM Ultra Plus XC Injectable Gel

        2. The objectives of this study are:

             1. To assess physician assessment of efficacy and incremental benefit following BOTOX
                Cosmetic and Juvederm for the treatment of moderate to severe facial wrinkles and
                folds;

             2. To assess patient perceptions of treatment outcomes and incremental benefit
                following BOTOX Cosmetic and Juvederm for the treatment of moderate to severe
                facial wrinkles and folds.

        3. Investigator and study sites:

             1. multicenter study

             2. 5 Sites: 2 in US, 2 in Canada, 1 in EU
    
  